(IPS) Ipsos - Ratings and Ratios
Surveys, Polling, Market Research, Data Analytics
Description: IPS Ipsos
Ipsos SA, a French multinational research and consulting firm, operates in the Research & Consulting Services sub-industry. The companys stock is listed as a common stock with the ticker symbol IPS.
To evaluate Ipsos financial health, we can examine its Income Tax Expense on a yearly basis. A thorough analysis of the companys financial statements would reveal its ability to manage tax liabilities and its impact on profitability. Key Performance Indicators (KPIs) such as the Effective Tax Rate (ETR) and tax-adjusted metrics like Return on Equity (RoE) can provide insights into Ipsos tax management efficiency.
Ipsos Market Capitalization stands at approximately €1.66 billion, indicating a mid-cap company. The stocks Price-to-Earnings (P/E) ratio is around 9.40, suggesting a relatively low valuation compared to its earnings. The Forward P/E ratio is even lower at 7.25, implying expected earnings growth. The companys RoE of 25.32% is a strong indicator of its profitability and ability to generate returns for shareholders.
The Research & Consulting Services industry is closely tied to economic drivers such as GDP growth, consumer spending, and business confidence. As a major player in this industry, Ipsos is likely to benefit from growth in these areas. Additionally, the increasing demand for market research and data analytics services, driven by the need for businesses to make informed decisions, is a key growth driver for the company.
To further analyze Ipsos stock performance, we can consider its beta of 0.887, indicating a relatively low volatility compared to the broader market. The companys stock price has fluctuated between €36.69 and €55.07 over the past 52 weeks, with a current price of €38.12. Average trading volume is around 45,838 shares, indicating a moderate level of liquidity.
IPS Stock Overview
| Market Cap in USD | 1,807m |
| Sub-Industry | Research & Consulting Services |
| IPO / Inception |
IPS Stock Ratings
| Growth Rating | -33.3% |
| Fundamental | 80.5% |
| Dividend Rating | 84.2% |
| Return 12m vs S&P 500 | -31.3% |
| Analyst Rating | - |
IPS Dividends
| Dividend Yield 12m | 5.14% |
| Yield on Cost 5y | 10.19% |
| Annual Growth 5y | 38.38% |
| Payout Consistency | 98.0% |
| Payout Ratio | 45.2% |
IPS Growth Ratios
| Growth Correlation 3m | -68.8% |
| Growth Correlation 12m | -72.9% |
| Growth Correlation 5y | 59.2% |
| CAGR 5y | -8.93% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.20 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.46 |
| Sharpe Ratio 12m | 0.27 |
| Alpha | -34.08 |
| Beta | 0.868 |
| Volatility | 26.47% |
| Current Volume | 97.6k |
| Average Volume 20d | 47.3k |
| Stop Loss | 34.8 (-3.4%) |
| Signal | -0.42 |
Piotroski VR‑10 (Strict, 0-10) 9.5
| Net Income (334.5m TTM) > 0 and > 6% of Revenue (6% = 259.3m TTM) |
| FCFTA 0.16 (>2.0%) and ΔFCFTA 7.65pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 6.00% (prev 9.40%; Δ -3.40pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.22 (>3.0%) and CFO 627.4m > Net Income 334.5m (YES >=105%, WARN >=100%) |
| Net Debt (377.5m) to EBITDA (765.3m) ratio: 0.49 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.38 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (43.5m) change vs 12m ago -2.30% (target <= -2.0% for YES) |
| Gross Margin 42.32% (prev 18.53%; Δ 23.79pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 157.6% (prev 132.4%; Δ 25.13pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 15.29 (EBITDA TTM 765.3m / Interest Expense TTM 36.5m) >= 6 (WARN >= 3) |
Altman Z'' 2.75
| (A) 0.09 = (Total Current Assets 946.6m - Total Current Liabilities 687.4m) / Total Assets 2.85b |
| (B) 0.02 = Retained Earnings (Balance) 53.2m / Total Assets 2.85b |
| (C) 0.20 = EBIT TTM 557.6m / Avg Total Assets 2.74b |
| (D) 0.69 = Book Value of Equity 983.3m / Total Liabilities 1.42b |
| Total Rating: 2.75 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 80.50
| 1. Piotroski 9.50pt = 4.50 |
| 2. FCF Yield 24.09% = 5.0 |
| 3. FCF Margin 10.75% = 2.69 |
| 4. Debt/Equity 0.44 = 2.41 |
| 5. Debt/Ebitda 0.49 = 2.31 |
| 6. ROIC - WACC (= 14.40)% = 12.50 |
| 7. RoE 22.97% = 1.91 |
| 8. Rev. Trend -22.47% = -1.69 |
| 9. EPS Trend 17.27% = 0.86 |
What is the price of IPS shares?
Over the past week, the price has changed by +1.18%, over one month by -3.12%, over three months by -11.93% and over the past year by -19.98%.
Is Ipsos a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IPS is around 30.33 EUR . This means that IPS is currently overvalued and has a potential downside of -15.8%.
Is IPS a buy, sell or hold?
What are the forecasts/targets for the IPS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 61.9 | 71.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 33.4 | -7.2% |
IPS Fundamental Data Overview
Market Cap EUR = 1.55b (1.55b EUR * 1.0 EUR.EUR)
P/E Trailing = 8.7824
P/E Forward = 6.3412
P/S = 0.6307
P/B = 1.1204
Beta = 0.868
Revenue TTM = 4.32b EUR
EBIT TTM = 557.6m EUR
EBITDA TTM = 765.3m EUR
Long Term Debt = 487.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 50.9m EUR (from shortTermDebt, last quarter)
Debt = 627.9m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 377.5m EUR (from netDebt column, last quarter)
Enterprise Value = 1.93b EUR (1.55b + Debt 627.9m - CCE 250.4m)
Interest Coverage Ratio = 15.29 (Ebit TTM 557.6m / Interest Expense TTM 36.5m)
FCF Yield = 24.09% (FCF TTM 464.3m / Enterprise Value 1.93b)
FCF Margin = 10.75% (FCF TTM 464.3m / Revenue TTM 4.32b)
Net Margin = 7.74% (Net Income TTM 334.5m / Revenue TTM 4.32b)
Gross Margin = 42.32% ((Revenue TTM 4.32b - Cost of Revenue TTM 2.49b) / Revenue TTM)
Gross Margin QoQ = 68.39% (prev 68.93%)
Tobins Q-Ratio = 0.68 (Enterprise Value 1.93b / Total Assets 2.85b)
Interest Expense / Debt = 2.72% (Interest Expense 17.1m / Debt 627.9m)
Taxrate = 26.60% (9.80m / 36.8m)
NOPAT = 409.3m (EBIT 557.6m * (1 - 26.60%))
Current Ratio = 1.38 (Total Current Assets 946.6m / Total Current Liabilities 687.4m)
Debt / Equity = 0.44 (Debt 627.9m / totalStockholderEquity, last quarter 1.43b)
Debt / EBITDA = 0.49 (Net Debt 377.5m / EBITDA 765.3m)
Debt / FCF = 0.81 (Net Debt 377.5m / FCF TTM 464.3m)
Total Stockholder Equity = 1.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.75% (Net Income 334.5m / Total Assets 2.85b)
RoE = 22.97% (Net Income TTM 334.5m / Total Stockholder Equity 1.46b)
RoCE = 28.69% (EBIT 557.6m / Capital Employed (Equity 1.46b + L.T.Debt 487.4m))
RoIC = 21.54% (NOPAT 409.3m / Invested Capital 1.90b)
WACC = 7.13% (E(1.55b)/V(2.18b) * Re(9.21%) + D(627.9m)/V(2.18b) * Rd(2.72%) * (1-Tc(0.27)))
Discount Rate = 9.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF Debug] Terminal Value 77.74% ; FCFE base≈369.9m ; Y1≈456.3m ; Y5≈778.6m
Fair Price DCF = 247.8 (DCF Value 10.69b / Shares Outstanding 43.1m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 17.27 | EPS CAGR: -58.19% | SUE: 0.0 | # QB: 0
Revenue Correlation: -22.47 | Revenue CAGR: -23.75% | SUE: N/A | # QB: 0